| 10195178 |
GPR40 agonists in anti-diabetic drug combinations |
Yin Liang |
2019-02-05 |
$80,901,000 |
| 8633184 |
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol |
Gee-Hong Kuo, Yan Zhang, Lan Shen, Songfeng Lu, Patricia Pelton |
2014-01-21 |
$49,918,000 |
| 8278268 |
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulators |
Jacqueline Bussolari, Xiaoli Chen, Bruce Conway, Hamish Ross, Rafael Severino |
2012-10-02 |
|
| 8242173 |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Alan R. DeAngelis, Gee-Hong Kuo, Patricia Pelton, Aihua Wang, Rui Zhang |
2012-08-14 |
$59,571,000 |
| 8183213 |
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
Jacqueline Bussolari, Xiaoli Chen, Bruce Conway, Hamish Ross, Rafael Severino |
2012-05-22 |
|
| 8147801 |
Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion |
James Martin Lenhard, Gregory C. Leo, Yin Liang, Tonya L. Martin |
2012-04-03 |
$38,531,000 |
| 8012963 |
3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors |
Gee-Hong Kuo, Thomas A. Rano, Aihua Wang, Catherine P. Prouty, Patricia Pelton |
2011-09-06 |
$73,184,000 |
| 7928238 |
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors |
Thomas A. Rano, Gee-Hong Kuo, Ellen Sieber-McMaster, Patricia Pelton, Aihua Wang |
2011-04-19 |
$53,502,000 |
| 7875744 |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Gee-Hong Kuo, Rui Zhang, Aihua Wang, Alan R. DeAngelis, Patricia Pelton |
2011-01-25 |
$42,118,000 |
| 7825110 |
Substituted spiroheterocycles |
Min Xiang, Mona Patel, Philip Rybczynski, Joseph Gunnet, Richard Look +3 more |
2010-11-02 |
$70,286,000 |
| 7825111 |
Substituted spiroheterocycles |
Min Xiang, Mona Patel, Philip Rybczynski, Joseph Gunnet, Richard Look +3 more |
2010-11-02 |
$70,286,000 |
| 7812053 |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Alan R. DeAngelis, Gee-Hong Kuo, Patricia Pelton, Aihua Wang, Rui Zhang |
2010-10-12 |
$77,069,000 |
| 7786135 |
Substituted pyrroline kinase inhibitors |
Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill +3 more |
2010-08-31 |
$45,211,000 |
| 7781450 |
Substituted pyrroline kinase inhibitors |
Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill +3 more |
2010-08-24 |
$48,795,000 |
| 7750048 |
GPR40 agonists |
Gee-Hong Kuo, Fengbin Song, Joseph Gunnet |
2010-07-06 |
$73,251,000 |
| 7749995 |
3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors |
Gee-Hong Kuo, Aihua Wang, Thomas A. Rano, Catherine P. Prouty, Patricia Pelton |
2010-07-06 |
$73,251,000 |
| 7678786 |
Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol |
Gee-Hong Kuo, Yan Zhang, Lan Shen, Songfeng Lu, Patricia Pelton |
2010-03-16 |
$119,247,000 |
| 7608634 |
Substituted pyrrolines as kinase inhibitors |
Han-Cheng Zhang, Bruce E. Maryanoff, David F. McComsey, Kimberly White, Hong Ye +2 more |
2009-10-27 |
$135,214,000 |
| 7598416 |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Gee-Hong Kuo, Rui Zhang, Aihua Wang, Alan R. DeAngelis, Patricia Pelton |
2009-10-06 |
$120,121,000 |
| 7425649 |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
Gee-Hong Kuo, Rui Zhang, Aihua Wang, Alan R. DeAngelis, Patricia Pelton |
2008-09-16 |
$875,328,000 |
| 7351857 |
Methods of using substituted tetralins and indanes |
Xiaoli Chen, Jung Lee, Jay M. Matthews, Philip Rybczynski |
2008-04-01 |
$95,713,000 |
| 7232906 |
Substituted pyrrolines as kinase inhibitors |
Han-Cheng Zhang, Bruce E. Maryanoff, David F. McComsey, Kimberly White, Hong Ye +2 more |
2007-06-19 |
$102,246,000 |
| 7125878 |
Substituted pyrroline kinase inhibitors |
Han-Cheng Zhang, Gee-Hong Kuo, Bruce E. Maryanoff, Hong Ye, David O'Neill +3 more |
2006-10-24 |
$162,105,000 |
| 6987110 |
Substituted pyrrolines as kinase inhibitors |
Han-Cheng Zhang, Bruce E. Maryanoff, Hong Ye, Bruce Conway |
2006-01-17 |
$80,637,000 |
| 6903109 |
Arylindenopyridines and related therapeutic and prophylactic methods |
Geoffrey Richard Heintzelman, Kristin Averill, John H. Dodd, Yuting Tang, Paul F. Jackson |
2005-06-07 |
|
